BJU International 2009-03-01

A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer.

Peter Schlegel

Index: BJU Int. 103 Suppl 2 , 7-13, (2009)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Histrelin CAS:76712-82-8	C₆₆H₈₆N₁₈O₁₂

Stability of peptide drugs in the colon.
2015-10-12
[Eur. J. Pharm. Sci. 78 , 31-6, (2015)]

Toward oral delivery of biopharmaceuticals: an assessment of...
2015-03-02
[Mol. Pharm. 12(3) , 966-73, (2015)]

Treatment and outcomes of precocious puberty: an update.
2013-06-01
[J. Clin. Endocrinol. Metab. 98(6) , 2198-207, (2013)]

Haploinsufficiency of Dmxl2, encoding a synaptic protein, ca...
2014-09-01
[PLoS Biol. 12(9) , e1001952, (2014)]

Resumption of puberty in girls and boys following removal of...
2014-04-01
[J. Pediatr. 164(4) , 912-916.e1, (2014)]